US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 24.920
  • +0.640+2.64%
Close Dec 20 16:00 ET
  • 25.010
  • +0.090+0.36%
Post 20:01 ET
11.07BMarket Cap9.81P/E (TTM)

Royalty Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
4.78%1.76B
-12.20%2.55B
-40.79%1.53B
-49.18%1.23B
-49.18%1.23B
-24.04%1.68B
-14.50%2.91B
-11.10%2.59B
-13.39%2.43B
-13.39%2.43B
-Cash and cash equivalents
1.45%950.05M
-18.80%1.76B
-57.33%843M
-72.12%477.01M
-72.12%477.01M
-5.56%936.45M
3.09%2.17B
10.28%1.98B
11.01%1.71B
11.01%1.71B
-Short-term investments
8.94%814.27M
7.29%788.6M
12.56%689.48M
5.54%756.74M
5.54%756.74M
-38.99%747.46M
-43.17%735.01M
-45.30%612.52M
-43.19%717.04M
-43.19%717.04M
Receivables
-34.32%24.9M
-33.06%23.58M
-42.18%22.23M
0.14%36.65M
0.14%36.65M
8.81%37.91M
-0.34%35.23M
-41.59%38.44M
-46.42%36.6M
-46.42%36.6M
-Other receivables
-34.32%24.9M
-33.06%23.58M
-42.18%22.23M
0.14%36.65M
0.14%36.65M
8.81%37.91M
-0.34%35.23M
-41.59%38.44M
-46.42%36.6M
-46.42%36.6M
Other current assets
-26.75%4.97M
-77.58%2.29M
9.63%5.01M
-95.80%3.8M
-95.80%3.8M
-92.51%6.78M
-84.77%10.22M
-15.18%4.57M
1,265.10%90.52M
1,265.10%90.52M
Total current assets
3.79%1.79B
-12.68%2.58B
-40.72%1.56B
-50.13%1.27B
-50.13%1.27B
-26.19%1.73B
-15.71%2.95B
-11.78%2.63B
-11.23%2.55B
-11.23%2.55B
Non current assets
Investments and advances
14.88%16.21B
6.45%15.05B
1.05%14.57B
6.13%15.1B
6.13%15.1B
-7.80%14.11B
-0.45%14.14B
0.15%14.41B
-2.73%14.23B
-2.73%14.23B
Other non current assets
111.70%42.79M
-6.30%27.56M
-83.99%4.49M
-77.99%6.52M
-77.99%6.52M
-33.98%20.21M
-11.98%29.41M
624.29%28.03M
614.81%29.63M
614.81%29.63M
Total non current assets
15.01%16.25B
6.42%15.08B
0.89%14.57B
5.96%15.11B
5.96%15.11B
-7.85%14.13B
-0.48%14.17B
0.32%14.44B
-2.59%14.26B
-2.59%14.26B
Total assets
13.79%18.04B
3.13%17.66B
-5.52%16.13B
-2.57%16.38B
-2.57%16.38B
-10.28%15.86B
-3.49%17.12B
-1.75%17.07B
-4.01%16.81B
-4.01%16.81B
Liabilities
Current liabilities
Payables
-12.25%101.2M
2.75%121.96M
-2.17%102.96M
-4.27%98.32M
-4.27%98.32M
-5.34%115.34M
-7.39%118.69M
-14.21%105.24M
-9.55%102.71M
-9.55%102.71M
-accounts payable
61.85%22.06M
303.10%23.42M
73.52%11.55M
91.82%15.17M
91.82%15.17M
-15.42%13.63M
-52.29%5.81M
-0.08%6.66M
40.68%7.91M
40.68%7.91M
-Dividends payable
-22.18%79.15M
-12.70%98.54M
-7.28%91.41M
-12.29%83.16M
-12.29%83.16M
-3.80%101.71M
-2.68%112.88M
-15.02%98.58M
-12.17%94.8M
-12.17%94.8M
Current accrued expenses
204.98%38.41M
3.86%56.25M
-4.58%12.6M
-4.58%51.68M
-4.58%51.68M
-4.58%12.6M
0.00%54.16M
0.00%13.2M
-6.13%54.16M
-6.13%54.16M
Current debt and capital lease obligation
--996.94M
----
----
----
----
----
--999.37M
--998.44M
--997.51M
--997.51M
-Current debt
--996.94M
----
----
----
----
----
--999.37M
--998.44M
--997.51M
--997.51M
Other current liabilities
--31.2M
--97.49M
--9.02M
-8.27%11.38M
-8.27%11.38M
----
----
----
--12.4M
--12.4M
Current liabilities
812.79%1.17B
-76.48%275.7M
-88.85%124.57M
-86.17%161.38M
-86.17%161.38M
-88.69%127.93M
542.92%1.17B
722.01%1.12B
581.33%1.17B
581.33%1.17B
Non current liabilities
Long term debt and capital lease obligation
7.82%6.61B
24.07%7.6B
0.27%6.14B
0.27%6.14B
0.27%6.14B
0.27%6.13B
-13.78%6.13B
-13.78%6.12B
-13.77%6.12B
-13.77%6.12B
-Long term debt
7.82%6.61B
24.07%7.6B
0.27%6.14B
0.27%6.14B
0.27%6.14B
0.27%6.13B
-13.78%6.13B
-13.78%6.12B
-13.77%6.12B
-13.77%6.12B
Other non current liabilities
-50.62%5.58M
218.13%27.04M
-73.82%3.22M
-64.00%900K
-64.00%900K
--11.3M
4.94%8.5M
--12.3M
--2.5M
--2.5M
Total non current liabilities
7.71%6.62B
24.34%7.63B
0.12%6.14B
0.24%6.14B
0.24%6.14B
0.29%6.14B
-14.19%6.14B
-13.60%6.14B
-13.74%6.12B
-13.74%6.12B
Total liabilities
24.13%7.78B
8.17%7.9B
-13.58%6.27B
-13.59%6.3B
-13.59%6.3B
-13.59%6.27B
-0.33%7.31B
0.21%7.25B
0.29%7.29B
0.29%7.29B
Shareholders'equity
Share capital
0.00%108K
-0.92%108K
0.00%108K
0.93%108K
0.93%108K
0.93%108K
1.87%109K
1.89%108K
0.94%107K
0.94%107K
-common stock
0.00%108K
-0.92%108K
0.00%108K
0.93%108K
0.93%108K
0.93%108K
1.87%109K
1.89%108K
0.94%107K
0.94%107K
Retained earnings
29.51%2.76B
5.56%2.38B
9.50%2.43B
28.14%2.52B
28.14%2.52B
-14.78%2.13B
-7.90%2.25B
-0.35%2.22B
-12.88%1.96B
-12.88%1.96B
Paid-in capital
2.52%4.11B
1.72%4.1B
8.96%4.07B
9.42%4.01B
9.42%4.01B
10.29%4.01B
12.90%4.03B
5.54%3.74B
4.52%3.67B
4.52%3.67B
Less: Treasury stock
1.26%2.66M
1.22%2.66M
-6.15%2.65M
-6.31%2.63M
-6.31%2.63M
-5.88%2.62M
-4.47%2.63M
3.36%2.83M
3.35%2.81M
3.35%2.81M
Gains losses not affecting retained earnings
----
----
----
--0
--0
----
----
----
--0
--0
Total stockholders'equity
11.91%6.87B
3.10%6.48B
9.17%6.5B
15.96%6.53B
15.96%6.53B
-0.21%6.14B
4.22%6.28B
3.05%5.95B
-2.57%5.63B
-2.57%5.63B
Noncontrolling interests
-1.67%3.39B
-7.26%3.28B
-13.04%3.36B
-8.71%3.56B
-8.71%3.56B
-19.19%3.45B
-19.38%3.53B
-11.37%3.87B
-12.85%3.9B
-12.85%3.9B
Total equity
7.03%10.26B
-0.63%9.75B
0.42%9.86B
5.87%10.08B
5.87%10.08B
-7.98%9.59B
-5.71%9.81B
-3.15%9.82B
-7.06%9.53B
-7.06%9.53B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 4.78%1.76B-12.20%2.55B-40.79%1.53B-49.18%1.23B-49.18%1.23B-24.04%1.68B-14.50%2.91B-11.10%2.59B-13.39%2.43B-13.39%2.43B
-Cash and cash equivalents 1.45%950.05M-18.80%1.76B-57.33%843M-72.12%477.01M-72.12%477.01M-5.56%936.45M3.09%2.17B10.28%1.98B11.01%1.71B11.01%1.71B
-Short-term investments 8.94%814.27M7.29%788.6M12.56%689.48M5.54%756.74M5.54%756.74M-38.99%747.46M-43.17%735.01M-45.30%612.52M-43.19%717.04M-43.19%717.04M
Receivables -34.32%24.9M-33.06%23.58M-42.18%22.23M0.14%36.65M0.14%36.65M8.81%37.91M-0.34%35.23M-41.59%38.44M-46.42%36.6M-46.42%36.6M
-Other receivables -34.32%24.9M-33.06%23.58M-42.18%22.23M0.14%36.65M0.14%36.65M8.81%37.91M-0.34%35.23M-41.59%38.44M-46.42%36.6M-46.42%36.6M
Other current assets -26.75%4.97M-77.58%2.29M9.63%5.01M-95.80%3.8M-95.80%3.8M-92.51%6.78M-84.77%10.22M-15.18%4.57M1,265.10%90.52M1,265.10%90.52M
Total current assets 3.79%1.79B-12.68%2.58B-40.72%1.56B-50.13%1.27B-50.13%1.27B-26.19%1.73B-15.71%2.95B-11.78%2.63B-11.23%2.55B-11.23%2.55B
Non current assets
Investments and advances 14.88%16.21B6.45%15.05B1.05%14.57B6.13%15.1B6.13%15.1B-7.80%14.11B-0.45%14.14B0.15%14.41B-2.73%14.23B-2.73%14.23B
Other non current assets 111.70%42.79M-6.30%27.56M-83.99%4.49M-77.99%6.52M-77.99%6.52M-33.98%20.21M-11.98%29.41M624.29%28.03M614.81%29.63M614.81%29.63M
Total non current assets 15.01%16.25B6.42%15.08B0.89%14.57B5.96%15.11B5.96%15.11B-7.85%14.13B-0.48%14.17B0.32%14.44B-2.59%14.26B-2.59%14.26B
Total assets 13.79%18.04B3.13%17.66B-5.52%16.13B-2.57%16.38B-2.57%16.38B-10.28%15.86B-3.49%17.12B-1.75%17.07B-4.01%16.81B-4.01%16.81B
Liabilities
Current liabilities
Payables -12.25%101.2M2.75%121.96M-2.17%102.96M-4.27%98.32M-4.27%98.32M-5.34%115.34M-7.39%118.69M-14.21%105.24M-9.55%102.71M-9.55%102.71M
-accounts payable 61.85%22.06M303.10%23.42M73.52%11.55M91.82%15.17M91.82%15.17M-15.42%13.63M-52.29%5.81M-0.08%6.66M40.68%7.91M40.68%7.91M
-Dividends payable -22.18%79.15M-12.70%98.54M-7.28%91.41M-12.29%83.16M-12.29%83.16M-3.80%101.71M-2.68%112.88M-15.02%98.58M-12.17%94.8M-12.17%94.8M
Current accrued expenses 204.98%38.41M3.86%56.25M-4.58%12.6M-4.58%51.68M-4.58%51.68M-4.58%12.6M0.00%54.16M0.00%13.2M-6.13%54.16M-6.13%54.16M
Current debt and capital lease obligation --996.94M----------------------999.37M--998.44M--997.51M--997.51M
-Current debt --996.94M----------------------999.37M--998.44M--997.51M--997.51M
Other current liabilities --31.2M--97.49M--9.02M-8.27%11.38M-8.27%11.38M--------------12.4M--12.4M
Current liabilities 812.79%1.17B-76.48%275.7M-88.85%124.57M-86.17%161.38M-86.17%161.38M-88.69%127.93M542.92%1.17B722.01%1.12B581.33%1.17B581.33%1.17B
Non current liabilities
Long term debt and capital lease obligation 7.82%6.61B24.07%7.6B0.27%6.14B0.27%6.14B0.27%6.14B0.27%6.13B-13.78%6.13B-13.78%6.12B-13.77%6.12B-13.77%6.12B
-Long term debt 7.82%6.61B24.07%7.6B0.27%6.14B0.27%6.14B0.27%6.14B0.27%6.13B-13.78%6.13B-13.78%6.12B-13.77%6.12B-13.77%6.12B
Other non current liabilities -50.62%5.58M218.13%27.04M-73.82%3.22M-64.00%900K-64.00%900K--11.3M4.94%8.5M--12.3M--2.5M--2.5M
Total non current liabilities 7.71%6.62B24.34%7.63B0.12%6.14B0.24%6.14B0.24%6.14B0.29%6.14B-14.19%6.14B-13.60%6.14B-13.74%6.12B-13.74%6.12B
Total liabilities 24.13%7.78B8.17%7.9B-13.58%6.27B-13.59%6.3B-13.59%6.3B-13.59%6.27B-0.33%7.31B0.21%7.25B0.29%7.29B0.29%7.29B
Shareholders'equity
Share capital 0.00%108K-0.92%108K0.00%108K0.93%108K0.93%108K0.93%108K1.87%109K1.89%108K0.94%107K0.94%107K
-common stock 0.00%108K-0.92%108K0.00%108K0.93%108K0.93%108K0.93%108K1.87%109K1.89%108K0.94%107K0.94%107K
Retained earnings 29.51%2.76B5.56%2.38B9.50%2.43B28.14%2.52B28.14%2.52B-14.78%2.13B-7.90%2.25B-0.35%2.22B-12.88%1.96B-12.88%1.96B
Paid-in capital 2.52%4.11B1.72%4.1B8.96%4.07B9.42%4.01B9.42%4.01B10.29%4.01B12.90%4.03B5.54%3.74B4.52%3.67B4.52%3.67B
Less: Treasury stock 1.26%2.66M1.22%2.66M-6.15%2.65M-6.31%2.63M-6.31%2.63M-5.88%2.62M-4.47%2.63M3.36%2.83M3.35%2.81M3.35%2.81M
Gains losses not affecting retained earnings --------------0--0--------------0--0
Total stockholders'equity 11.91%6.87B3.10%6.48B9.17%6.5B15.96%6.53B15.96%6.53B-0.21%6.14B4.22%6.28B3.05%5.95B-2.57%5.63B-2.57%5.63B
Noncontrolling interests -1.67%3.39B-7.26%3.28B-13.04%3.36B-8.71%3.56B-8.71%3.56B-19.19%3.45B-19.38%3.53B-11.37%3.87B-12.85%3.9B-12.85%3.9B
Total equity 7.03%10.26B-0.63%9.75B0.42%9.86B5.87%10.08B5.87%10.08B-7.98%9.59B-5.71%9.81B-3.15%9.82B-7.06%9.53B-7.06%9.53B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.